MBII - Marrone Bio Innovations Inc. (MBII) CEO Kevin Helash on Q3 2020 Results - Earnings Call Transcript
Marrone Bio Innovations, Inc. (MBII) Q3 2020 Results Earnings Conference Call November 09, 2020, 04:30 PM ET Company Participants Linda Moore - General Counsel Kevin Helash - CEO Jim Boyd - President and CFO Kevin Hammill - Chief Commercial Officer Conference Call Participants Ben Klieve - National Security Bobby Burleson - Canaccord Amit Dayal - H.C. Wainright Presentation Operator Good day, and welcome to the Marrone Bio Innovations Third Quarter 2020 Earnings Conference Call. Today's conference is being recorded. At this time, I'd like to turn the conference over to Linda Moore, General Counsel. Please go ahead, ma’am. Linda Moore Good afternoon, everyone, and thank you for joining our call. Welcome to the 2020 third quarter earnings conference call for Marrone Bio Innovations. On the call today are CEO, Kevin Helash; CFO, Jim Boyd; and Chief Commercial Officer, Kevin Hammill. If you would please refer to slide 2, I would
For further details see:
Marrone Bio Innovations, Inc. (MBII) CEO Kevin Helash on Q3 2020 Results - Earnings Call Transcript